CHEN; Andrew Xian
Patent Applications and Registrations
Patent applications and USPTO patent grants for CHEN; Andrew Xian.The latest application filed is for "methods and compositions for treating edema refractory to oral diuretics".
Company Profile
8.35.49
- CHEN; Andrew Xian - San Diego CA
- Chen; Andrew Xian - US
Patent Activity
| Patent | Date |
|---|---|
| Methods And Compositions For Treating Edema Refractory To Oral Diuretics App 20220287996 - RADHAKRISHNAN; Balasingam ; et al. | 2022-09-15 |
| Methods and compositions for treating edema refractory to oral diuretics Grant 11,260,038 - Radhakrishnan , et al. March 1, 2 | 2022-03-01 |
| Methods and compositions for treating edema refractory to oral diuretics Grant 11,123,319 - Radhakrishnan , et al. September 21, 2 | 2021-09-21 |
| Methods And Compositions For Treating Edema Refractory To Oral Diuretics App 20210169833 - RADHAKRISHNAN; Balasingam ; et al. | 2021-06-10 |
| Sustained Release Compositions Using Wax-like Materials App 20210113469 - Chen; Andrew Xian ; et al. | 2021-04-22 |
| Stabilized glucagon solutions Grant 10,888,616 - Chen , et al. January 12, 2 | 2021-01-12 |
| Sustained release compositions using wax-like materials Grant 10,888,521 - Chen , et al. January 12, 2 | 2021-01-12 |
| Aqueous Formulation For Insoluble Drugs App 20200368159 - CHEN; Andrew Xian ; et al. | 2020-11-26 |
| Chewable sustained release formulations Grant 10,668,012 - Chen , et al. | 2020-06-02 |
| Aqueous solution formulations of vancomycin Grant 10,376,560 - Chen A | 2019-08-13 |
| Stabilized Glucagon Solutions App 20180236079 - CHEN; Hailiang ; et al. | 2018-08-23 |
| Parenteral compositions of celecoxib Grant 9,968,621 - Okumu , et al. May 15, 2 | 2018-05-15 |
| Aqueous Solution Formulations Of Vancomycin App 20170304396 - CHEN; ANDREW XIAN | 2017-10-26 |
| Phospholipid Depot App 20170246109 - CHEN; Hailiang ; et al. | 2017-08-31 |
| Phospholipid Depot App 20170189532 - Chen; Andrew Xian ; et al. | 2017-07-06 |
| Phospholipid depot Grant 9,682,040 - Chen , et al. June 20, 2 | 2017-06-20 |
| Phospholipid Depot App 20170056326 - Chen; Hailiang ; et al. | 2017-03-02 |
| Phospholipid depot Grant 9,522,169 - Chen , et al. December 20, 2 | 2016-12-20 |
| Phospholipid depot Grant 9,517,202 - Chen , et al. December 13, 2 | 2016-12-13 |
| Parental Compositions Of Celecoxib App 20160354390 - Okumu; Franklin ; et al. | 2016-12-08 |
| Parenteral compositions of celecoxib Grant 9,446,056 - Okumu , et al. September 20, 2 | 2016-09-20 |
| Oral formulations of kinase inhibitors Grant 9,375,402 - Chen , et al. June 28, 2 | 2016-06-28 |
| Nanoemulsion composition containing vitamin K Grant 9,370,486 - Chen June 21, 2 | 2016-06-21 |
| Treating or preventing pain using spicamycin derivatives Grant 9,248,098 - Didsbury , et al. February 2, 2 | 2016-02-02 |
| Phospholipid Depot App 20150306173 - Chen; Hailiang ; et al. | 2015-10-29 |
| Phospholipid depot Grant 9,132,144 - Chen , et al. September 15, 2 | 2015-09-15 |
| Parenteral Compositions Of Celecoxib App 20150224121 - Okumu; Franklin ; et al. | 2015-08-13 |
| Stabilized Glucagon Nanoemulsions App 20140378381 - Chen; Andrew Xian ; et al. | 2014-12-25 |
| Compositions for delivery of insoluble agents Grant 8,877,746 - Chen , et al. November 4, 2 | 2014-11-04 |
| Diclofenac Parenteral Compositions App 20140275261 - Okumu; Franklin ; et al. | 2014-09-18 |
| Gel Compositions App 20140249077 - Chen; Andrew Xian ; et al. | 2014-09-04 |
| Oral Formulations Of Kinase Inhibitors App 20140206692 - Chen; Andrew Xian ; et al. | 2014-07-24 |
| Use Of Storage Stable Viscous Phospholipid Depot To Treat Wounds App 20140155320 - Chen; Hailiang ; et al. | 2014-06-05 |
| Solid dispersion of alpha-ketoamide derivatives Grant 8,697,746 - Chen , et al. April 15, 2 | 2014-04-15 |
| Low oil emulsion compositions for delivering taxoids and other insoluble drugs Grant 8,557,861 - Chen October 15, 2 | 2013-10-15 |
| Nanoemulsion Composition Containing Vitamin K App 20130189316 - Chen; Andrew Xian | 2013-07-25 |
| Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof Grant 8,470,873 - Chen June 25, 2 | 2013-06-25 |
| Anti-viral pharmaceutical compositions Grant 8,470,346 - Chen June 25, 2 | 2013-06-25 |
| Sustained Release Pharmaceutical Compositions for Highly Water Soluble Drugs App 20130089608 - Chen; Andrew Xian ; et al. | 2013-04-11 |
| Compositions for Delivery of Insoluble Agents App 20130079334 - Chen; Hailiang ; et al. | 2013-03-28 |
| Methods For Reducing Vein Irritation App 20130029918 - Chen; Andrew Xian | 2013-01-31 |
| Phospholipid Depot App 20120316108 - Chen; Andrew Xian ; et al. | 2012-12-13 |
| Compositions For Delivery Of Insoluble Agents App 20120225118 - Chen; Hailiang ; et al. | 2012-09-06 |
| Sustained release pharmaceutical compositions for highly water soluble drugs Grant 8,221,792 - Chen , et al. July 17, 2 | 2012-07-17 |
| Methods for reducing vein irritation Grant 8,222,268 - Chen July 17, 2 | 2012-07-17 |
| Phospholipid Depot App 20120046220 - Chen; Hailiang ; et al. | 2012-02-23 |
| Compositions For Delivering Highly Water Soluble Drugs App 20120046310 - Chen; Andrew Xian | 2012-02-23 |
| Solid Dispersion Of Alpha-ketoamide Derivatives App 20120016020 - CHEN; Andrew Xian ; et al. | 2012-01-19 |
| Treating or Preventing Pain Using Spicamycin Derivatives App 20110237536 - Didsbury; John R. ; et al. | 2011-09-29 |
| Compositions for delivering highly water soluble drugs Grant 8,026,250 - Chen September 27, 2 | 2011-09-27 |
| Anti-viral Pharmaceutical Compositions App 20110223259 - Chen; Andrew Xian | 2011-09-15 |
| Anti-viral pharmaceutical compositions Grant 7,968,122 - Chen June 28, 2 | 2011-06-28 |
| Compositions For Delivering Highly Water Soluble Drugs App 20110082168 - Chen; Andrew Xian | 2011-04-07 |
| Compositions for delivering highly water soluble drugs Grant 7,871,632 - Chen January 18, 2 | 2011-01-18 |
| Oral Formulations For Picoplatin App 20100310661 - Chen; Andrew Xian ; et al. | 2010-12-09 |
| Chewable Sustained Release Formulations App 20100062988 - Chen; Andrew Xian ; et al. | 2010-03-11 |
| Sustained Release Compositions Using Wax-like Materials App 20080220079 - Chen; Andrew Xian ; et al. | 2008-09-11 |
| Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof App 20070207173 - Chen; Andrew Xian | 2007-09-06 |
| Sustained release pharmaceutical compositions for highly water soluble drugs App 20070020335 - Chen; Andrew Xian ; et al. | 2007-01-25 |
| Low oil emulsion compositions for delivering taxoids and other insoluble drugs App 20060067952 - Chen; Andrew Xian | 2006-03-30 |
| Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof App 20060024360 - Chen; Andrew Xian | 2006-02-02 |
| Compositions for delivering highly water soluble drugs App 20060008480 - Chen; Andrew Xian | 2006-01-12 |
| Phospholipid compositions and methods for their preparation and use App 20050287180 - Chen, Andrew Xian | 2005-12-29 |
| Anti-viral pharmaceutical compositions App 20050232895 - Chen, Andrew Xian | 2005-10-20 |
| Elemene compositions containing liquid oil App 20050186230 - Chen, Andrew Xian | 2005-08-25 |
| Pharmaceutical compositions for delivering macrolides App 20050049209 - Chen, Andrew Xian | 2005-03-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 